Exact Mass: 439.23923120000006
Exact Mass Matches: 439.23923120000006
Found 500 metabolites which its exact mass value is equals to given mass value 439.23923120000006
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Leukotriene E4
C23H37NO5S (439.23923120000006)
Leukotriene E4 (LTE4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels, which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4 activates contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney (PMID: 12607939, 12432945, 6311078). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent and are able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis through receptor-mediated G-protein linked signaling pathways. Leukotriene E4 (LTE4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels, which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4, activate contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney. (PMID: 12607939, 12432945, 6311078)
Militarinone B
C26H33NO5 (439.23586080000007)
A natural product found in Isaria farinosa.
LysoPE(15:0/0:0)
C20H42NO7P (439.26987520000006)
LysoPE(15:0/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(15:0/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
LysoPE(0:0/15:0)
C20H42NO7P (439.26987520000006)
LysoPE(0:0/15:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/15:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
Pivmecillinam
C21H33N3O5S (439.2140808000001)
Pivmecillinam is only found in individuals that have used or taken this drug. It is a mecillinam prodrug, a pivaloyloxymethyl ester of amdinocillin that is well absorbed orally, but broken down to amdinocillin in the intestinal mucosa. It is active against gram-negative organisms and used as for amdinocillin. [PubChem]Pivmecillinam interferes with the biosynthesis of the bacterial cell wall however its activity is slightly different from that of other penicillins and cephalosporins J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
O-Desmethylvenlafaxine glucuronide
C22H33NO8 (439.22060580000004)
O-Desmethylvenlafaxine glucuronide is a metabolite of venlafaxine (brand name: Effexor or Efexor). Venlafaxine is a bicyclic antidepressant and is usually categorized as a serotonin-norepinephrine reuptake inhibitor (SNRI), but it has been referred to as a serotonin-norepinephrine-dopamine reuptake inhibitor. It works by blocking the transporter reuptake proteins for key neurotransmitters affecting mood, thereby leaving more active neurotransmitters in the synapse.
11-trans-LTE4
C23H37NO5S (439.23923120000006)
11-trans-LTE4 is also known as 11-trans-Leukotriene e4 or 11t-LTE4. 11-trans-LTE4 is considered to be practically insoluble (in water) and acidic. 11-trans-LTE4 is an eicosanoid lipid molecule
Dodecanoyl-sn-glycero-3-phosphocholine (isomer 1) (LPC(12:0) i1) † ‡
C20H42NO7P (439.26987520000006)
Dodecanoyl-sn-glycero-3-phosphocholine
C20H42NO7P (439.26987520000006)
(5S,6R,7E,9E,11Z,14Z)-6-((R)-2-Amino-2-carboxyethylthio)-5-hydroxyicosa-7,9,11,14-tetraenoic acid
C23H37NO5S (439.23923120000006)
(S)-3-(6-Methoxypyridin-3-yl)-3-(2-oxo-3-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl)imidazolidin-1-yl)propanoic acid
C23H29N5O4 (439.22194340000004)
Nvp-aew541
(E,E)-Numismine|1,29-Seco-lunarin|1,29-seco-lunarine|Numismin|numismine
C25H33N3O4 (439.2470938000001)
18-demethyl-14-deacetylpubescenine|18-O-demethyl-14-O-deacetylpubescenine
11-[2-amino-3-(4'-O-methyl-alpha-ribopyranosyloxy)phenyl]undecanoic acid
NVP-AEW541
LPC 12:0
C20H42NO7P (439.26987520000006)
Acquisition and generation of the data is financially supported in part by CREST/JST.
1-lauroyl-sn-glycero-3-phosphocholine
C20H42NO7P (439.26987520000006)
A 1-O-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as lauroyl (dodecanoyl)
Ala Gly His Arg
Ala Gly Arg His
Ala His Gly Arg
Ala His Asn Val
Ala His Arg Gly
Ala His Val Asn
Ala Asn His Val
Ala Asn Val His
Ala Pro Pro Arg
C19H33N7O5 (439.25430480000006)
Ala Pro Arg Pro
C19H33N7O5 (439.25430480000006)
Ala Arg Gly His
Ala Arg His Gly
Ala Arg Pro Pro
C19H33N7O5 (439.25430480000006)
Ala Val His Asn
Ala Val Asn His
Gly Ala His Arg
Gly Ala Arg His
Gly His Ala Arg
Gly His Ile Asn
Gly His Lys Val
C19H33N7O5 (439.25430480000006)
Gly His Leu Asn
Gly His Asn Ile
Gly His Asn Leu
Gly His Gln Val
Gly His Arg Ala
Gly His Val Lys
C19H33N7O5 (439.25430480000006)
Gly His Val Gln
Gly Ile His Asn
Gly Ile Asn His
Gly Lys His Val
C19H33N7O5 (439.25430480000006)
Gly Lys Val His
C19H33N7O5 (439.25430480000006)
Gly Leu His Asn
Gly Leu Asn His
Gly Asn His Ile
Gly Asn His Leu
Gly Asn Ile His
Gly Asn Leu His
Gly Gln His Val
Gly Gln Val His
Gly Arg Ala His
Gly Arg His Ala
Gly Val His Lys
C19H33N7O5 (439.25430480000006)
Gly Val His Gln
Gly Val Lys His
C19H33N7O5 (439.25430480000006)
Gly Val Gln His
His Ala Gly Arg
His Ala Asn Val
His Ala Arg Gly
His Ala Val Asn
His Gly Ala Arg
His Gly Ile Asn
His Gly Lys Val
C19H33N7O5 (439.25430480000006)
His Gly Leu Asn
His Gly Asn Ile
His Gly Asn Leu
His Gly Gln Val
His Gly Arg Ala
His Gly Val Lys
C19H33N7O5 (439.25430480000006)
His Gly Val Gln
His Ile Gly Asn
His Ile Asn Gly
His Lys Gly Val
C19H33N7O5 (439.25430480000006)
His Lys Val Gly
C19H33N7O5 (439.25430480000006)
His Leu Gly Asn
His Leu Asn Gly
His Asn Ala Val
His Asn Gly Ile
His Asn Gly Leu
His Asn Ile Gly
His Asn Leu Gly
His Asn Val Ala
His Gln Gly Val
His Gln Val Gly
His Arg Ala Gly
His Arg Gly Ala
His Val Ala Asn
His Val Gly Lys
C19H33N7O5 (439.25430480000006)
His Val Gly Gln
His Val Lys Gly
C19H33N7O5 (439.25430480000006)
His Val Asn Ala
His Val Gln Gly
Ile Gly His Asn
Ile Gly Asn His
Ile His Gly Asn
Ile His Asn Gly
Ile Asn Gly His
Ile Asn His Gly
Ile Asn Pro Pro
C20H33N5O6 (439.24307180000005)
Ile Pro Asn Pro
C20H33N5O6 (439.24307180000005)
Ile Pro Pro Asn
C20H33N5O6 (439.24307180000005)
Lys Gly His Val
C19H33N7O5 (439.25430480000006)
Lys Gly Val His
C19H33N7O5 (439.25430480000006)
Lys His Gly Val
C19H33N7O5 (439.25430480000006)
Lys His Val Gly
C19H33N7O5 (439.25430480000006)
Lys Val Gly His
C19H33N7O5 (439.25430480000006)
Lys Val His Gly
C19H33N7O5 (439.25430480000006)
Leu Gly His Asn
Leu Gly Asn His
Leu His Gly Asn
Leu His Asn Gly
Leu Asn Gly His
Leu Asn His Gly
Leu Asn Pro Pro
C20H33N5O6 (439.24307180000005)
Leu Pro Asn Pro
C20H33N5O6 (439.24307180000005)
Leu Pro Pro Asn
C20H33N5O6 (439.24307180000005)
Asn Ala His Val
Asn Ala Val His
Asn Gly His Ile
Asn Gly His Leu
Asn Gly Ile His
Asn Gly Leu His
Asn His Ala Val
Asn His Gly Ile
Asn His Gly Leu
Asn His Ile Gly
Asn His Leu Gly
Asn His Val Ala
Asn Ile Gly His
Asn Ile His Gly
Asn Ile Pro Pro
C20H33N5O6 (439.24307180000005)
Asn Leu Gly His
Asn Leu His Gly
Asn Leu Pro Pro
C20H33N5O6 (439.24307180000005)
Asn Pro Ile Pro
C20H33N5O6 (439.24307180000005)
Asn Pro Leu Pro
C20H33N5O6 (439.24307180000005)
Asn Pro Pro Ile
C20H33N5O6 (439.24307180000005)
Asn Pro Pro Leu
C20H33N5O6 (439.24307180000005)
Asn Val Ala His
Asn Val His Ala
Pro Ala Pro Arg
C19H33N7O5 (439.25430480000006)
Pro Ala Arg Pro
C19H33N7O5 (439.25430480000006)
Pro Ile Asn Pro
C20H33N5O6 (439.24307180000005)
Pro Ile Pro Asn
C20H33N5O6 (439.24307180000005)
Pro Leu Asn Pro
C20H33N5O6 (439.24307180000005)
Pro Leu Pro Asn
C20H33N5O6 (439.24307180000005)
Pro Asn Ile Pro
C20H33N5O6 (439.24307180000005)
Pro Asn Leu Pro
C20H33N5O6 (439.24307180000005)
Pro Asn Pro Ile
C20H33N5O6 (439.24307180000005)
Pro Asn Pro Leu
C20H33N5O6 (439.24307180000005)
Pro Pro Ala Arg
C19H33N7O5 (439.25430480000006)
Pro Pro Ile Asn
C20H33N5O6 (439.24307180000005)
Pro Pro Leu Asn
C20H33N5O6 (439.24307180000005)
Pro Pro Asn Ile
C20H33N5O6 (439.24307180000005)
Pro Pro Asn Leu
C20H33N5O6 (439.24307180000005)
Pro Pro Gln Val
C20H33N5O6 (439.24307180000005)
Pro Pro Arg Ala
C19H33N7O5 (439.25430480000006)
Pro Pro Val Gln
C20H33N5O6 (439.24307180000005)
Pro Gln Pro Val
C20H33N5O6 (439.24307180000005)
Pro Gln Val Pro
C20H33N5O6 (439.24307180000005)
Pro Arg Ala Pro
C19H33N7O5 (439.25430480000006)
Pro Arg Pro Ala
C19H33N7O5 (439.25430480000006)
Pro Val Pro Gln
C20H33N5O6 (439.24307180000005)
Pro Val Gln Pro
C20H33N5O6 (439.24307180000005)
Gln Gly His Val
Gln Gly Val His
Gln His Gly Val
Gln His Val Gly
Gln Pro Pro Val
C20H33N5O6 (439.24307180000005)
Gln Pro Val Pro
C20H33N5O6 (439.24307180000005)
Gln Val Gly His
Gln Val His Gly
Gln Val Pro Pro
C20H33N5O6 (439.24307180000005)
Arg Ala Gly His
Arg Ala His Gly
Arg Ala Pro Pro
C19H33N7O5 (439.25430480000006)
Arg Gly Ala His
Arg Gly His Ala
Arg His Ala Gly
Arg His Gly Ala
Arg Pro Ala Pro
C19H33N7O5 (439.25430480000006)
Arg Pro Pro Ala
C19H33N7O5 (439.25430480000006)
Val Ala His Asn
Val Ala Asn His
Val Gly His Lys
C19H33N7O5 (439.25430480000006)
Val Gly His Gln
Val Gly Lys His
C19H33N7O5 (439.25430480000006)
Val Gly Gln His
Val His Ala Asn
Val His Gly Lys
C19H33N7O5 (439.25430480000006)
Val His Gly Gln
Val His Lys Gly
C19H33N7O5 (439.25430480000006)
Val His Asn Ala
Val His Gln Gly
Val Lys Gly His
C19H33N7O5 (439.25430480000006)
Val Lys His Gly
C19H33N7O5 (439.25430480000006)
Val Asn Ala His
Val Asn His Ala
Val Pro Pro Gln
C20H33N5O6 (439.24307180000005)
Val Pro Gln Pro
C20H33N5O6 (439.24307180000005)
Val Gln Gly His
Val Gln His Gly
Val Gln Pro Pro
C20H33N5O6 (439.24307180000005)
11-trans-LTE4
C23H37NO5S (439.23923120000006)
A leukotriene that is the 11-trans-isomer of leukotriene E4.
Platelet-activating factor
C20H42NO7P (439.26987520000006)
PC(O-6:0/6:0)[U]
C20H42NO7P (439.26987520000006)
PC(6:0/O-6:0)[U]
C20H42NO7P (439.26987520000006)
1-Dodecanoyllysolecithin
C20H42NO7P (439.26987520000006)
Lysolauroyllecithin
C20H42NO7P (439.26987520000006)
PC(0:0/12:0)[U]
C20H42NO7P (439.26987520000006)
14,15-Leukotriene E4
C23H37NO5S (439.23923120000006)
14,15-LTE4
C23H37NO5S (439.23923120000006)
LPE(15:0)
C20H42NO7P (439.26987520000006)
PIVMECILLINAM
C21H33N3O5S (439.2140808000001)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Leukotriene E
C23H37NO5S (439.23923120000006)
A leukotriene that is (7E,9E,11Z,14Z)-icosa-7,9,11,14-tetraenoic acid substituted by a hydroxy group at position 5 (5S) and an L-cystein-S-yl group at position 6 (6R).
LPE 15:0
C20H42NO7P (439.26987520000006)
LPE O-15:1;O
C20H42NO7P (439.26987520000006)
Sulfamisterin
C19H37NO8S (439.22397620000004)
(S)-2-[5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazol-2-y
C24H34BN3O4 (439.26422340000005)
(2S)-1-{[{2[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}[(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)amino]]acetyl}pyrrolidine-2-carbonitrile
C24H33N5O3 (439.2583268000001)
N-(2-NITROPHENYLSULFENYL)-L-SERINE (DICYCLOHEXYLAMMONIUM) SALT
C21H33N3O5S (439.2140808000001)
2-tert-Butyl-4-[3-(dimethylvinylsilanyl)propoxy]-6-(5-methoxybenzotriazol-2-yl)-phenol
1-(1-([1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YL)-1-((TERT-BUTYLDIMETHYLSILYL)OXY)PROPAN-2-YL)-3-(M-TOLYL)UREA
Propanedinitrile,[2-(2-propyl)-6-[2-(2,3,6,7-tetrahydro-2,2,7,7-tetramethyl-1H,5H-benzo[ij]quinolizin-9-yl)ethenyl]-4H-pyran
C29H33N3O (439.26234880000004)
(1R,3S,4S)-3-[6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-BENZIMIDAZOL-2-YL]-2-AZABICYCLO[2.2.1]HEPTANE-2-CARBOXYLIC ACID 1,1-DIMETHYLETHYL ESTER
C24H34BN3O4 (439.26422340000005)
{1-[2-Oxo-2-({4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl}amino)ethyl]cyclopentyl}acetic acid hydrochloride (1:1)
C21H34ClN5O3 (439.2350044000001)
1,5-diphenyl-2-[3-(4-pyridin-2-ylpiperazin-1-yl)propyl]pyrazol-3-one
Panobinostat Lactate
C24H29N3O5 (439.21071040000004)
C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
Temiverine hydrochloride hydrate
C24H38ClNO4 (439.24892180000006)
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
6-Amino-4-[3-ethoxy-4-[2-(4-morpholinyl)ethoxy]phenyl]-3-ethyl-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile
C23H29N5O4 (439.22194340000004)
(1S)-1-{4-[(9AR)-Octahydro-2H-pyrido[1,2-A]pyrazin-2-YL]phenyl}-2-phenyl-1,2,3,4-tetrahydroisoquinolin-6-OL
C29H33N3O (439.26234880000004)
N-(2-phenylphenyl)-8-(4-pyridin-3-yltriazol-1-yl)octanamide
[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] pentadecanoate
C20H42NO7P (439.26987520000006)
2-dodecanoyl-sn-glycero-3-phosphocholine
C20H42NO7P (439.26987520000006)
A 2-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as dodecanoyl.
2-(3-ethoxypropylamino)-8-methyl-5-oxo-N-(2-oxolanylmethyl)-3-dipyrido[1,2-pyrimidinecarboxamide
C23H29N5O4 (439.22194340000004)
7-[3-(1-Azetidinylmethyl)cyclobutyl]-5-(4-phenylmethoxyphenyl)-4-pyrrolo[2,3-d]pyrimidinamine
1-decyl-2-acetyl-sn-glycero-3-phosphocholine
C20H42NO7P (439.26987520000006)
A 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine in which the alkyl group is specified as decyl.
(2s,3r)-2-Amino-(2-hydroxy-methyl)-12-oxo-3-(sulphooxy)octadecanoic acid
C19H37NO8S (439.22397620000004)
2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[[(2-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1R)-1-phenylethyl]acetamide
C24H29N3O5 (439.21071040000004)
2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[[(2-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1R)-1-phenylethyl]acetamide
C24H29N3O5 (439.21071040000004)
(2S,3S,3aR,9bR)-1-(cyclopropylmethyl)-7-(2-fluorophenyl)-3-(hydroxymethyl)-6-oxo-N-propyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide
C25H33N3O4 (439.2470938000001)
(1R,9S,10S,11S)-N-(cyclopropylmethyl)-5-(3-fluorophenyl)-10-(hydroxymethyl)-6-oxo-12-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1S,9R,10R,11R)-N-(cyclopropylmethyl)-5-(3-fluorophenyl)-10-(hydroxymethyl)-6-oxo-12-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(2S,3S,3aR,9bR)-1-ethyl-7-(3-fluorophenyl)-3-(hydroxymethyl)-2-(piperidine-1-carbonyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide
C25H33N3O4 (439.2470938000001)
N-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
C21H33N3O5S (439.2140808000001)
N-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
C21H33N3O5S (439.2140808000001)
N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylpyrazine-2-carboxamide
C23H29N5O4 (439.22194340000004)
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide
C25H33N3O4 (439.2470938000001)
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide
C25H33N3O4 (439.2470938000001)
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide
C25H33N3O4 (439.2470938000001)
N-[(4R,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C25H33N3O4 (439.2470938000001)
N-[(4R,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C25H33N3O4 (439.2470938000001)
N-[(5S,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C25H33N3O4 (439.2470938000001)
N-[(5R,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C25H33N3O4 (439.2470938000001)
N-[(5S,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C25H33N3O4 (439.2470938000001)
2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[[(2-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1S)-1-phenylethyl]acetamide
C24H29N3O5 (439.21071040000004)
2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[[(2-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1S)-1-phenylethyl]acetamide
C24H29N3O5 (439.21071040000004)
2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[[(2-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1S)-1-phenylethyl]acetamide
C24H29N3O5 (439.21071040000004)
2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[[(2-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1S)-1-phenylethyl]acetamide
C24H29N3O5 (439.21071040000004)
2-[(2R,5S,6R)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]-N-[2-(1-piperidinyl)ethyl]acetamide
C21H33N3O5S (439.2140808000001)
2-[(2S,5S,6R)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]-N-[2-(1-piperidinyl)ethyl]acetamide
C21H33N3O5S (439.2140808000001)
2-[(2S,5R,6R)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]-N-[2-(1-piperidinyl)ethyl]acetamide
C21H33N3O5S (439.2140808000001)
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(3-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(phenylmethyl)acetamide
C24H29N3O5 (439.21071040000004)
(2R,3R,3aS,9bS)-N-(cyclohexylmethyl)-7-(2-fluorophenyl)-3-(hydroxymethyl)-6-oxo-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide
[(8S,9S,10R)-9-[4-[(E)-2-phenylethenyl]phenyl]-6-(pyridin-3-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
C29H33N3O (439.26234880000004)
[(8R,9R,10S)-9-[4-[(E)-2-phenylethenyl]phenyl]-6-(pyridin-3-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
C29H33N3O (439.26234880000004)
[(8S,9R,10R)-9-[4-[(E)-2-phenylethenyl]phenyl]-6-(pyridin-3-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
C29H33N3O (439.26234880000004)
N,N-dimethyl-3-[4-[(1S,5R)-3-(1-oxo-2-phenylethyl)-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzamide
1-[(2S,3S)-1-[(4-fluorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-2-(4-morpholinyl)ethanone
1-[(1R)-2-[cyclopentyl(oxo)methyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone
C25H33N3O4 (439.2470938000001)
(6S,7S,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-4-[2-(4-morpholinyl)-1-oxoethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H33N3O4 (439.2470938000001)
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide
C25H33N3O4 (439.2470938000001)
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide
C25H33N3O4 (439.2470938000001)
N-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
C21H33N3O5S (439.2140808000001)
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide
C25H33N3O4 (439.2470938000001)
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide
C25H33N3O4 (439.2470938000001)
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide
C25H33N3O4 (439.2470938000001)
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide
C25H33N3O4 (439.2470938000001)
N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
C21H33N3O5S (439.2140808000001)
N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
C21H33N3O5S (439.2140808000001)
N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylpyrazine-2-carboxamide
C23H29N5O4 (439.22194340000004)
N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylpyrazine-2-carboxamide
C23H29N5O4 (439.22194340000004)
N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylpyrazine-2-carboxamide
C23H29N5O4 (439.22194340000004)
N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylpyrazine-2-carboxamide
C23H29N5O4 (439.22194340000004)
N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylpyrazine-2-carboxamide
C23H29N5O4 (439.22194340000004)
N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylpyrazine-2-carboxamide
C23H29N5O4 (439.22194340000004)
N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylpyrazine-2-carboxamide
C23H29N5O4 (439.22194340000004)
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide
C25H33N3O4 (439.2470938000001)
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide
C25H33N3O4 (439.2470938000001)
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide
C25H33N3O4 (439.2470938000001)
N-[(4S,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C25H33N3O4 (439.2470938000001)
N-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C25H33N3O4 (439.2470938000001)
N-[(4R,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C25H33N3O4 (439.2470938000001)
N-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C25H33N3O4 (439.2470938000001)
N-[(4R,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C25H33N3O4 (439.2470938000001)
N-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C25H33N3O4 (439.2470938000001)
N-[(5R,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C25H33N3O4 (439.2470938000001)
N-[(5R,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C25H33N3O4 (439.2470938000001)
N-[(5S,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C25H33N3O4 (439.2470938000001)
N-[(5R,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C25H33N3O4 (439.2470938000001)
2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[[(2-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1R)-1-phenylethyl]acetamide
C24H29N3O5 (439.21071040000004)
2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[[(2-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1R)-1-phenylethyl]acetamide
C24H29N3O5 (439.21071040000004)
2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[[(2-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1S)-1-phenylethyl]acetamide
C24H29N3O5 (439.21071040000004)
2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[[(2-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1R)-1-phenylethyl]acetamide
C24H29N3O5 (439.21071040000004)
2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[[(2-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1S)-1-phenylethyl]acetamide
C24H29N3O5 (439.21071040000004)
2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[[(2-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1R)-1-phenylethyl]acetamide
C24H29N3O5 (439.21071040000004)
2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[[(2-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1R)-1-phenylethyl]acetamide
C24H29N3O5 (439.21071040000004)
2-[(2S,5R,6S)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]-N-[2-(1-piperidinyl)ethyl]acetamide
C21H33N3O5S (439.2140808000001)
2-[(2R,5R,6S)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]-N-[2-(1-piperidinyl)ethyl]acetamide
C21H33N3O5S (439.2140808000001)
2-[(2S,5S,6S)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]-N-[2-(1-piperidinyl)ethyl]acetamide
C21H33N3O5S (439.2140808000001)
2-[(2R,5R,6R)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]-N-[2-(1-piperidinyl)ethyl]acetamide
C21H33N3O5S (439.2140808000001)
2-[(2R,5S,6S)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]-N-[2-(1-piperidinyl)ethyl]acetamide
C21H33N3O5S (439.2140808000001)
(2R,3R,3aS,9bS)-1-(cyclopropylmethyl)-7-(2-fluorophenyl)-3-(hydroxymethyl)-6-oxo-N-propyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-1-ethyl-7-(3-fluorophenyl)-3-(hydroxymethyl)-2-[oxo(1-piperidinyl)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
[(8R,9R,10R)-9-[4-[(E)-2-phenylethenyl]phenyl]-6-(pyridin-3-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
C29H33N3O (439.26234880000004)
[(8R,9S,10R)-9-[4-[(E)-2-phenylethenyl]phenyl]-6-(pyridin-3-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
C29H33N3O (439.26234880000004)
[(8R,9S,10S)-9-[4-[(E)-2-phenylethenyl]phenyl]-6-(pyridin-3-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
C29H33N3O (439.26234880000004)
[(8S,9R,10S)-9-[4-[(E)-2-phenylethenyl]phenyl]-6-(pyridin-3-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
C29H33N3O (439.26234880000004)
[(8S,9S,10S)-9-[4-[(E)-2-phenylethenyl]phenyl]-6-(pyridin-3-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
C29H33N3O (439.26234880000004)
1-[(2S,3R)-1-[(4-fluorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-2-(4-morpholinyl)ethanone
1-[(2R,3R)-1-[(4-fluorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-2-(4-morpholinyl)ethanone
(2S)-N-{(2S)-1-[(3S)-3-carboxy-3,4-dihydroisoquinolin-2(1H)-yl]-1-oxopropan-2-yl}-1-ethoxy-1-oxo-4-phenylbutan-2-aminium
2,2-dimethylpropanoyloxymethyl (2S,5S,6R)-6-(azepan-1-ylmethylideneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
C21H33N3O5S (439.2140808000001)
(1S,9R,10R,11R)-12-(cyclobutanecarbonyl)-10-(hydroxymethyl)-11-(piperidine-1-carbonyl)-5-[(E)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
C25H33N3O4 (439.2470938000001)
(1R,9S,10S,11S)-12-(cyclobutanecarbonyl)-10-(hydroxymethyl)-11-(piperidine-1-carbonyl)-5-[(E)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
C25H33N3O4 (439.2470938000001)
(1S,9R,10R,11R)-N-[(4-fluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-5-[(E)-prop-1-enyl]-12-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1R,9S,10S,11S)-N-[(4-fluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-5-[(E)-prop-1-enyl]-12-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(2R,3R,3aS,9bS)-1-[(3-fluorophenyl)methyl]-3-(hydroxymethyl)-6-oxo-7-[(Z)-prop-1-enyl]-N-propyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2-Acetyloxy-3-decoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C20H42NO7P (439.26987520000006)
[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] dodecanoate
(2-Butanoyloxy-3-octoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C20H42NO7P (439.26987520000006)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl] heptanoate
C20H42NO7P (439.26987520000006)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonoxypropan-2-yl] hexanoate
C20H42NO7P (439.26987520000006)
(3-Nonoxy-2-propanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C20H42NO7P (439.26987520000006)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] propanoate
C20H42NO7P (439.26987520000006)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] acetate
C20H42NO7P (439.26987520000006)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] butanoate
C20H42NO7P (439.26987520000006)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] pentanoate
C20H42NO7P (439.26987520000006)
[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-heptanoyloxypropyl] heptanoate
(2-Hexanoyloxy-3-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
(3-Acetyloxy-2-nonanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
(2-Octanoyloxy-3-propanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] nonanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] octanoate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] undecanoate
(3-Butanoyloxy-2-heptanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] decanoate
1-pentadecanoyl-glycero-3-phosphoethanolamine
C20H42NO7P (439.26987520000006)
eoxin E4
C23H37NO5S (439.23923120000006)
A leukotriene that is the 14R-(S-cysteinyl),15S-hydroxy derivative of (5Z,8Z,10E,12E)-icosa-7,9,11,14-tetraenoic acid.
1-(2-methoxy-6Z-tetradecenyl)-sn-glycero-3-phosphoethanolamine
C20H42NO7P (439.26987520000006)
MePC(10:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
CP-868388 (free base)
C26H33NO5 (439.23586080000007)
CP-868388 free base is a potent, selective and orally active PPARα agonist with a Ki value of 10.8 nM. CP-868388 free base has little or no affinity for PPARβ (Ki of 3.47 μM) and PPARγ. CP-868388 free base has hypolipidemic and anti-inflammatory actions[1].
Denifanstat
Denifanstat (TVB-2640) is an orally active and potent Fatty Acid Synthase (FASN) inhibitor with an IC50 of 0.052 μM and an EC50 of 0.072 μM. Denifanstat has the potential for fatty liver disease and cancer research[1][2].
11-{2-amino-3-[(3,4-dihydroxy-5-methoxyoxan-2-yl)oxy]phenyl}undecanoic acid
(1r,2r,3r,4r,5s,6r,8s,9r,10s,13r,16r,17r)-11-ethyl-16-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,5,6,8,17-pentol
9-ethyl-4,9-dihydroxy-8-methyl-4-(sec-butyl)-2,7,11-trioxa-16-azatricyclo[11.5.1.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione
C22H33NO8 (439.22060580000004)
(1r,4s,8r,9r,14s,20r)-4-hydroxy-4,9-diisopropyl-8-methyl-2,7,12-trioxa-17-azatricyclo[12.5.1.0¹⁷,²⁰]icosane-3,6,11-trione
11-ethyl-18-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,6,8,9,16-pentol
(1s,10s,11r,13s,14s,15s)-14-hydroxy-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-2-en-11-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
C26H33NO5 (439.23586080000007)
(2e,4e,6r)-n-[(1s,2r,4's,5r,5's,6s)-4-chloro-5,5'-dihydroxy-7-oxaspiro[bicyclo[4.1.0]heptane-2,2'-oxolan]-3-en-4'-yl]-4,6-dimethyldodeca-2,4-dienimidic acid
C23H34ClNO5 (439.2125384000001)
3'-acetylheliosupine
C22H33NO8 (439.22060580000004)
{"Ingredient_id": "HBIN007878","Ingredient_name": "3'-acetylheliosupine","Alias": "NA","Ingredient_formula": "C22H33NO8","Ingredient_Smile": "CC=C(C)C(=O)OC1CCN2C1C(=CC2)COC(=O)C(C(C)OC(=O)C)(C(C)(C)O)O","Ingredient_weight": "439.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "37193","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "6431047","DrugBank_id": "NA"}
(1s,2r,3r,4s,5s,6s,8r,9r,10s,13s,16s,17r,18s)-11-ethyl-13-(hydroxymethyl)-6,18-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,9,16-tetrol
(4e)-n-[(2e)-3-chloro-2-(3-hydroxy-6-oxocyclohex-1-en-1-yl)prop-2-en-1-yl]-7-methoxytetradec-4-enimidic acid
C24H38ClNO4 (439.24892180000006)
(1s,2r,3r,4r,5s,6s,8r,9s,10s,13s,16s,17r,18r)-11-ethyl-13-(hydroxymethyl)-6,18-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,9,16-tetrol
n-[3-chloro-2-(3-hydroxy-6-oxocyclohex-1-en-1-yl)prop-2-en-1-yl]-7-methoxytetradec-4-enimidic acid
C24H38ClNO4 (439.24892180000006)
11-ethyl-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,9,16,18-pentol
14-hydroxy-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-2-en-11-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
C26H33NO5 (439.23586080000007)
(1r,4s,8r,9s,19r)-4-[(2s)-butan-2-yl]-9-ethyl-4,9-dihydroxy-8-methyl-2,7,11-trioxa-16-azatricyclo[11.5.1.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione
C22H33NO8 (439.22060580000004)
(4e,7s)-n-[(2e)-3-chloro-2-[(3s)-3-hydroxy-6-oxocyclohex-1-en-1-yl]prop-2-en-1-yl]-7-methoxytetradec-4-enimidic acid
C24H38ClNO4 (439.24892180000006)
5-hydroxy-2-[hydroxy(4-hydroxyphenyl)methyl]-4-[(2e,4e,6e,8r,10r)-6,8,10-trimethyldodeca-2,4,6-trienoyl]-1,2-dihydropyrrol-3-one
C26H33NO5 (439.23586080000007)
13-(methoxymethyl)-11-propyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,6,8,9,16,18-hexol
(1r,2r,3s,4s,5r,6s,8s,9s,10r,13s,16s,17s)-11-ethyl-4,6,16-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-2,3,8,13-tetrol
(1s,2r,3r,4s,5s,6s,8r,9s,10s,13s,16s,17r,18r)-11-ethyl-13-(hydroxymethyl)-6,18-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,9,16-tetrol
(1s,7as)-7-({[(2s)-2-[(1s)-1-(acetyloxy)ethyl]-2,3-dihydroxy-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate
C22H33NO8 (439.22060580000004)
11-ethyl-13-(hydroxymethyl)-6,8-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,9,16,18-tetrol
(2e,4e,6r)-n-[(1r,2s,4's,5s,5's,6r)-4-chloro-5,5'-dihydroxy-7-oxaspiro[bicyclo[4.1.0]heptane-2,2'-oxolan]-3-en-4'-yl]-4,6-dimethyldodeca-2,4-dienimidic acid
C23H34ClNO5 (439.2125384000001)
(1s,2r,3r,4r,5s,6s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,9,16,18-pentol
(2s,4z)-5-hydroxy-2-[(s)-hydroxy(4-hydroxyphenyl)methyl]-4-[(2e,4e,6e,8r,10r)-1-hydroxy-6,8,10-trimethyldodeca-2,4,6-trien-1-ylidene]-2h-pyrrol-3-one
C26H33NO5 (439.23586080000007)
(3e,17e)-5,16,22-trihydroxy-6,11,15-triazaspiro[bicyclo[17.3.1]tricosane-2,1'-cyclohexane]-1(23),3,5,15,17,19,21-heptaen-4'-one
C25H33N3O4 (439.2470938000001)
(1s,2r,3r,4s,5s,6s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-13-(hydroxymethyl)-6,18-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,9,16-tetrol
(2e,4e)-n-{4-chloro-5,5'-dihydroxy-7-oxaspiro[bicyclo[4.1.0]heptane-2,2'-oxolan]-3-en-4'-yl}-4,6-dimethyldodeca-2,4-dienimidic acid
C23H34ClNO5 (439.2125384000001)
(1s,7ar)-7-({[(2r)-2-[(1s)-1-(acetyloxy)ethyl]-2,3-dihydroxy-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate
C22H33NO8 (439.22060580000004)
(5s)-5-(6-aminopurin-9-yl)-1-(4-hydroxy-3-methoxyphenyl)dodecan-3-one
C24H33N5O3 (439.2583268000001)
(1s,2r,3r,4s,5s,6s,8r,9r,10s,13s,16s,17r,18s)-11-ethyl-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,9,16,18-pentol
5-hydroxy-2-[hydroxy(4-hydroxyphenyl)methyl]-4-(1-hydroxy-6,8,10-trimethyldodeca-2,4,6-trien-1-ylidene)-2h-pyrrol-3-one
C26H33NO5 (439.23586080000007)
(1r,2r,3s,4r,4ar,8ar)-2-hydroxy-3,4,8,8a-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-1,2,3,4a,5,6-hexahydronaphthalen-1-yl pyridine-3-carboxylate
C26H33NO5 (439.23586080000007)
(4z)-5-hydroxy-2-[hydroxy(4-hydroxyphenyl)methyl]-4-[(2e,4e,6e,8r,10r)-1-hydroxy-6,8,10-trimethyldodeca-2,4,6-trien-1-ylidene]-2h-pyrrol-3-one
C26H33NO5 (439.23586080000007)
11-ethyl-13-(hydroxymethyl)-6,18-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,9,16-tetrol
7-{[(1r,2s,4as,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-5-(acetyloxy)-1,3-benzoxazol-6-yl acetate
C26H33NO5 (439.23586080000007)
(1s,10s,11r,13s,14r,15s)-14-hydroxy-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-2-en-11-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
C26H33NO5 (439.23586080000007)
5-hydroxy-3-{[7-(2-hydroxy-3-methoxy-3-methylbutyl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6-methyl-1,6-dihydropyrazin-2-one
C25H33N3O4 (439.2470938000001)
(1r,2r,3r,4r,5r,6s,8r,9r,10r,13r,16r,17s,18s)-11-ethyl-18-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,6,8,9,16-pentol
(1r)-7-({[3-(acetyloxy)-2-hydroxy-2-(2-hydroxypropan-2-yl)butanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate
C22H33NO8 (439.22060580000004)
7-({[3-(acetyloxy)-2-hydroxy-2-(2-hydroxypropan-2-yl)butanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 2-methylbut-2-enoate
C22H33NO8 (439.22060580000004)
5,16,22-trihydroxy-6,11,15-triazaspiro[bicyclo[17.3.1]tricosane-2,1'-cyclohexane]-1(23),3,5,15,17,19,21-heptaen-4'-one
C25H33N3O4 (439.2470938000001)
(1s,2r,3r,4s,5s,6s,8r,9s,10s,13s,16s,17r,18r)-11-ethyl-13-(hydroxymethyl)-6,8-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,9,16,18-tetrol
(3z,6s)-3-({7-[(2s)-2-hydroxy-3-methoxy-3-methylbutyl]-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl}methylidene)-6-methyl-6h-pyrazine-2,5-diol
C25H33N3O4 (439.2470938000001)
(2r,4z)-5-hydroxy-2-[(r)-hydroxy(4-hydroxyphenyl)methyl]-4-[(2e,4e,6e,8r,10r)-1-hydroxy-6,8,10-trimethyldodeca-2,4,6-trien-1-ylidene]-2h-pyrrol-3-one
C26H33NO5 (439.23586080000007)